STAAR Surgical Quarterly Cash Flow Statement
NASDAQ: STAAHealth CareOphthalmic GoodsUSD
21.67-0.71 (-3.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
STAAR Surgical free cash flow
In the quarter ended Jul 3, 2026, STAAR Surgical generated $19.7 million of operating cash flow and spent $494,000 on capital expenditures. That left free cash flow of $19.2 million, a free-cash-flow margin of 20.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
STAAR Surgical cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-07-03 | Q1 20262026-04-03 | Q4 20252026-01-02 | Q3 20252025-09-26 | Q2 20252025-06-27 | Q1 20252025-03-28 | Q4 20242024-12-27 | Q3 20242024-09-27 | Q2 20242024-06-28 | Q1 20242024-03-29 | Q4 20232023-12-29 | Q3 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 8.06M | 5.21M | -18.31M | 8.88M | -16.81M | -54.21M | -34.23M | 9.98M | 7.38M | -3.34M | 7.76M | 4.82M |
| Net Income growth (YoY) | — | — | — | -10.98% | -327.84% | — | -541.31% | +107.18% | +21.69% | -223.21% | +14.68% | -53.06% |
| Depreciation & Amortization | 2.39M | 2.11M | 2.01M | 2.00M | 1.98M | 2.34M | 2.38M | 1.76M | 1.52M | 1.24M | 1.37M | 1.34M |
| Stock-Based Compensation | 6.56M | 4.82M | 8.61M | 8.16M | 7.80M | 6.01M | 4.67M | 7.16M | 9.04M | 6.34M | 182.00K | 8.85M |
| Change in Working Capital | -9.86M | -30.79M | 8.33M | -27.34M | -10.38M | 30.18M | 27.73M | -14.13M | -28.17M | 27.35M | 15.86M | -25.50M |
| Operating Cash Flow | 19.69M | -21.70M | -3.91M | 2.67M | -27.25M | -5.73M | 642.00K | 3.82M | -10.41M | 21.68M | 31.97M | -5.97M |
| Capital Expenditures | -494.00K | -443.00K | -1.68M | -883.00K | -1.79M | -1.47M | -5.72M | -6.23M | -6.24M | -5.20M | -3.09M | -9.19M |
| Investing Cash Flow | -1.37M | 2.15M | -19.41M | 5.28M | 25.12M | 35.35M | -19.50M | -35.24M | -20.67M | 16.19M | 22.40M | 31.84M |
| Share Repurchases | — | — | 0 | -1.98M | — | — | — | — | — | — | — | — |
| Financing Cash Flow | -1.50M | -1.69M | -50.00K | 983.00K | -4.54M | -948.00K | -110.00K | 1.61M | 163.00K | 4.06M | 367.00K | 7.11M |
| Net Change in Cash | 16.71M | -21.29M | -23.00M | 9.02M | -5.98M | 28.95M | -19.84M | -28.77M | -31.25M | 40.99M | 55.61M | 32.74M |
| Free Cash Flow | 19.20M | -22.14M | -5.59M | 1.78M | -29.04M | -7.20M | -5.08M | -2.42M | -16.65M | 16.48M | 28.88M | -15.16M |
This table shows 12 quarterly periods of STAAR Surgical's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow STAA's reporting calendar. What is a cash flow statement?